KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Equity (2016 - 2025)

Teva Pharmaceutical Industries' Return on Equity history spans 10 years, with the latest figure at 0.19% for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 52.0% year-over-year to 0.19%, compared with a TTM value of 0.19% through Dec 2025, up 52.0%, and an annual FY2025 reading of 0.21%, up 50.0% over the prior year.
  • Return on Equity for Q4 2025 was 0.19% at Teva Pharmaceutical Industries, up from 0.09% in the prior quarter.
  • The five-year high for Return on Equity was 0.19% in Q4 2025, with the low at 0.38% in Q1 2021.
  • Average Return on Equity over 5 years is 0.14%, with a median of 0.12% recorded in 2022.
  • Year-over-year, Return on Equity plummeted -35bps in 2021 and then skyrocketed 52bps in 2025.
  • Tracing TEVA's Return on Equity over 5 years: stood at 0.04% in 2021, then plummeted by -807bps to 0.28% in 2022, then surged by 71bps to 0.08% in 2023, then tumbled by -318bps to 0.33% in 2024, then surged by 156bps to 0.19% in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Return on Equity are 0.19% (Q4 2025), 0.09% (Q3 2025), and 0.03% (Q2 2025).